Donald L. Trump, MD; Eric Bartel, BS; Myron Pozniak, MD
Cisplatin-bleomycin-based combination chemotherapy is curative for patients with extensive metastatic germ cell cancer (1, 2). Optimal management of these patients requires repeated serologic and radiographic assessment to monitor regression of disease after chemotherapy. If masses are seen by radiography after chemotherapy and serum markers are normal, surgical removal of these masses is indicated. Surgery will either confirm the eradication of all malignancy by revealing only mature teratoma or necrosis and fibrosis in these masses or reveal residual cancer requiring additional therapy (1, 2). We have noted the appearance of new nodular pulmonary infiltrates by computed tomographic (CT) scan of the
Trump DL, Bartel E, Pozniak M. Nodular Pneumonitis after Chemotherapy for Germ Cell Tumors. Ann Intern Med. ;109:431–432. doi: 10.7326/0003-4819-109-5-431
Download citation file:
Published: Ann Intern Med. 1988;109(5):431-432.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use